AOBiome Competitors and Similar CompaniesClear all
AOBiome's competitors and similar companies include Vyome Therapeutics, Verge Therapeutics and Rallybio.
 AOBiome AOBiome is a pioneer in bacterial therapy.
We represent a new approach to skin health that focuses on the restoring good bacteria to your biome |  Vyome Therapeutics Vyome Therapeutics is a biopharmaceutical company engaged in the development of novel drugs for antibiotic-resistant acne and other opportunist pathogens. |  Verge Therapeutics Verge Therapeutics is a company that specializes in metabolic therapeutics solutions. |  Rallybio Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins. | |
Founding Date | Founding Date 2013 | Founding Date 2010 | Founding Date 2017 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations Princeton, US HQ Delhi, IN Vadodara, IN | Locations Durham, US HQ | Locations New Haven, US HQ Farmington, US |
Employees | Employees 16 | Employees 19 | Employees 1 | Employees 28 |
Funding | ||||
Latest funding round | Latest funding round $ 30m (over 9 years ago) | Latest funding round $ 21.9m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 38.7m | Total funding raised $ 48.2m | Total funding raised N/A | Total funding raised $ 182m |
For sources of this data, please see the company profile
View Company Profiles
Vyome Therapeutics
HQ
Princeton, US
Employees
19
Vyome Therapeutics is a biopharmaceutical company engaged in the development of novel drugs for antibiotic-resistant acne and other opportunist pathogens.
View companyVerge Therapeutics
HQ
Durham, US
Employees
1
Verge Therapeutics is a company that specializes in metabolic therapeutics solutions.
View companyRallybio
HQ
New Haven, US
Employees
28
Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins.
View company